Skip to main content

Table 7 Follow-up data (multiple statements were possible)

From: Treatment of coronary bifurcation lesions: stent-covering of the side branch with and without PCI of the side branch: a retrospective analysis of all consecutive patients

  Covering SB without PCI SB (group A) N Covering SB + PCI SB (group B) N Difference CI; P
Re-PCI MB, In-segment (no., percent) 5 (7.9%) 63 4 (11.8%) 34 1.55a (0.39; 6.19) 0.54
Re-PCI SB, In-segment (no., percent) 3 (4.8%) 63 3 (8.8%) 34 1.94a (0.37; 10.16) 0.44
Definite stent thrombosis ( no., percent) 0 (0%) 63 3 (8.8%) 34 −0.088b 0.041c
CABG related to the target lesion (no., percent) 2 (3.2%) 63 0 (0%) 34 0.032a 0.54
TLR (no., percent) 10 (15.9%) 63 10 (29.4%) 34 2.21a (0.81; 6.01) 0.12
PCI target vessel, non-target lesion or CABG not related to target lesion (no., percent) 0 (0%) 63 1 (2.9%) 34 −0.029b 0.35c
TVR (no., percent) 10 (15.9%) 63 11 (32.4%) 34 2.53a (0. 95; 6.80) 0.07
Cardiac death (no., percent) 5 (7.9%) 63 5 (14.7%) 34 2.00a (0.54; 7.47) 0.30
All MACE (no., percent) 15 (23.8%) 63 16 (47.1%) 34 2.84a (1.17; 6.92) 0.02
PCI non-target vessel (no., percent) 6 (9.5%) 63 5 (14.7%) 34 1.64a (0.46; 5.82) 0.45
Diagnostic cardiac catheterization without PCI (no., percent) 3 (4.8%) 63 2 (5.9%) 34 1.25a (0.20; 7.87) 0.81
Non-cardiac death (no., percent) 2 (3.2%) 63 0 (0%) 34 0.032b 0.54c
Lost of follow-up (no., percent) 1 (1.6%) 64 0 (0%) 34 −0.016b 1.00c
Follow-up duration, months (mean, range, SD) 14.1 (0–41; 13.1) 63 12.3 (1–46; 12.8) 34 1.79b (−3.70; 7.27) 0.52
  1. a Odds ratio; b Difference in means; c From a Fisher’s exact test.